Search Results - "de Leeuw, Ivo"

Insulin Detemir Is Associated With More Predictable Glycemic Control and Reduced Risk of Hypoglycemia Than NPH Insulin in Patients With Type 1 Diabetes on a Basal-Bolus Regimen With Premeal Insulin Aspart by VAGUE, Philippe, SELAM, Jean-Louis, SKEIE, Svein, DE LEEUW, Ivo, ELTE, Jan W. F, HAAHR, Hanne, KRISTENSEN, Allan, DRAEGER, Eberhard

“…Insulin Detemir Is Associated With More Predictable Glycemic Control and Reduced Risk of Hypoglycemia Than NPH Insulin in Patients With Type 1 Diabetes on a…”
Get full text

Impact of Overweight on Chronic Microvascular Complications in Type 1 Diabetic Patients by De Block, Christophe E.M, De Leeuw, Ivo H, Van Gaal, Luc F

“…OBJECTIVE:--To investigate a possible association of BMI with retinopathy and neuropathy in type 1 diabetes. Retinopathy and neuropathy may not only be related…”
Get full text

Autoimmune Gastritis in Type 1 Diabetes: A Clinically Oriented Review by De Block, Christophe E. M., De Leeuw, Ivo H., Van Gaal, Luc F.

“…Context: Autoimmune gastritis and pernicious anemia are common autoimmune disorders, being present in up to 2% of the general population. In patients with type…”
Get full text

Current concepts in gastric motility in diabetes mellitus by De Block, Christophe E M, De Leeuw, Ivo H, Pelckmans, Paul A, Van Gaal, Luc F

“…This review addresses the current concepts in our understanding of the epidemiology, mechanisms, symptoms, clinical consequences, diagnosis and treatment of…”
Get more information

Delayed Gastric Emptying and Gastric Autoimmunity in Type 1 Diabetes by DE BLOCK, Christophe E. M, DE LEEUW, Ivo H, PELCKMANS, Paul A, CALLENS, Dirk, MADAY, Emöke, VAN GAAL, Luc F

“…Delayed Gastric Emptying and Gastric Autoimmunity in Type 1 Diabetes Christophe E.M. De Block , MD 1 , Ivo H. De Leeuw , MD, PHD 1 , Paul A. Pelckmans , MD,…”
Get full text

Autoimmune gastropathy in type 1 diabetic patients with parietal cell antibodies: Histological and clinical findings by DE BLOCK, Christophe E. M, DE LEEUW, Ivo H, BOGERS, Johannes J. P. M, PELCKMANS, Paul A, IEVEN, Margareta M, VAN MARCK, Eric A. E, VAN ACKER, Kristien L, VAN GAAL, Luc F

“…Approximately 15-20% of type 1 diabetic patients exhibit parietal cell antibodies (PCAs) targeting gastric H+/K+ATPase. We examined whether iron deficiency…”
Get full text

Neuroendocrine Tumor Markers and Enterochromaffin-Like Cell Hyper/Dysplasia in Type 1 Diabetes by DE BLOCK, Christophe E. M, COLPIN, Gert, BOUILLON, Roger, VAN GAAL, Luc F, THIELEMANS, Kristof, COOPMANS, Willy, BOGERS, Johannes J. P. M, PELCKMANS, Paul A, VAN MARCK, Eric A. E, VAN HOOF, Viviane, MARTIN, Manou, DE LEEUW, Ivo H

“…Neuroendocrine Tumor Markers and Enterochromaffin-Like Cell Hyper/Dysplasia in Type 1 Diabetes Christophe E.M. De Block , MD, PHD 1 , Gert Colpin 1 , Kristof…”
Get full text

Relation between Disease Phenotype and HLA-DQ Genotype in Diabetic Patients Diagnosed in Early Adulthood by Weets, Ilse, Siraux, Valerie, Daubresse, Jean-Claude, De Leeuw, Ivo H., Féry, Francoise, Keymeulen, Bart, Krzentowski, Georges, Letiexhe, Michel, Mathieu, Chantal, Nobels, Frank, Rottiers, Raoul, Scheen, André, Van Gaal, Luc, Schuit, Frans C., Van Der Auwera, Bart, Rui, Mao, De Pauw, Pieter, Kaufman, Leonard, Gorus, Frans K.

“…We investigated inaugural disease phenotype in relation to the presence or absence of diabetes-associated autoantibodies and human leukocyte antigen (HLA) DQ…”
Get full text

Antioxidant status and lipoprotein peroxidation in chronic fatigue syndrome by y Keenoy, Begoña Manuel, Moorkens, Greta, Vertommen, Jan, De Leeuw, Ivo

“…The aetiology and pathogenesis of the Chronic Fatigue Syndrome (CFS) are still largely unresolved. Accompanying metabolic disorders such as selective n-6 fatty…”
Get full text

The incidence of type 1 diabetes in the age group 0-39 years has not increased in Antwerp (Belgium) between 1989 and 2000 evidence for earlier disease manifestation by WEETS, Ilse, DE LEEUW, Ivo H, GORUS, Frans K, DU CAJU, Marc V. L, ROOMAN, Raoul, KEYMEULEN, Bart, MATHIEU, Chantal, ROTTIERS, Raoul, DAUBRESSE, Jean-Claude, ROCOUR-BRUMIOUL, Danielle, PIPELEERS, Daniel G

“…A worldwide increase in the incidence of childhood type 1 diabetes has been observed. Because in various countries the majority of new type 1 diabetic patients…”
Get full text

Postprandial glucose monitoring in type 1 diabetes mellitus: use of a continuous subcutaneous monitoring device by Manuel-y-Keenoy, Begoña, Vertommen, Jan, Abrams, Pascale, Van Gaal, Luc, De Leeuw, Ivo, Messeri, Dimitri, Poscia, Alessandro

“…Background Pre‐prandial glucose gives insufficient information on glycemic excursions throughout the day. We aimed to test a continuous subcutaneous…”
Get full text

Use of an islet cell antibody assay to identify type 1 diabetic patients with rapid decrease in C-peptide levels after clinical onset by DECOCHEZ, K, KEYMEULEN, B, KAUFMAN, L, PIPELEERS, D. G, GORUS, F. K, SOMERS, G, DORCHY, H, DE LEEUW, I. H, MATHIEU, C, ROTTIERS, R, WINNOCK, F, ELST, K. V, WEETS, I

“…To investigate whether the presence of antibody markers at diagnosis could help predict the rapid decrease in residual beta-cell function noted in some, but…”
Get full text

Platelet prothrombinase activity, a final pathway platelet procoagulant activity, is overexpressed in type 1 diabetes: no relationship with mean platelet volume or background retinopathy by van der Planken, M G, Vertessen, F J, Vertommen, J, Engelen, W, Berneman, Z N, De Leeuw, I

“…There is overwhelming evidence that platelets from diabetic individuals are hyperreactive, not only when microvascular complications are apparent, but already…”
Get more information

Autoimmune hepatitis, autoimmune gastritis, and gastric carcinoid in a type 1 diabetic patient: A case report by De Block, Christophe E.M, De Leeuw, Ivo H, Pelckmans, Paul A, Michielsen, Peter P, Bogers, Johannes J.P.M, Van Marck, Eric A.E, Van Gaal, Luc F

“…The history of a 45-year-old male type 1 diabetic patient is presented. At the age of 29 years, he was diagnosed to have an autoimmune hepatitis with incipient…”
Get full text

Autoimmune Gastropathy in Type 1 Diabetic Patients With Parietal Cell Antibodies by De Block, Christophe E.M., De Leeuw, Ivo H., Bogers, Johannes J.P.M., Pelckmans, Paul A., Ieven, Margareta M., Van Marck, Eric A.E., Van Acker, Kristien L., Van Gaal, Luc F.

“…Autoimmune Gastropathy in Type 1 Diabetic Patients With Parietal Cell Antibodies Histological and clinical findings Christophe E.M. De Block , MD, PHD 1 , Ivo…”
Get full text

Repaglinide improves blood glucose control in sulphonylurea-naive type 2 diabetes by Van Gaal, Luc F., Van Acker, Kristien L., De Leeuw, Ivo H.

“…The prandial glucose regulator repaglinide has a rapid onset of action, a short half-life and is metabolised mainly by the liver. Here we report the findings…”
Get full text

The Incidence of Type 1 Diabetes in the Age Group 0–39 Years Has Not Increased in Antwerp (Belgium) Between 1989 and 2000 by Weets, Ilse, De Leeuw, Ivo H., Du Caju, Marc V.L., Rooman, Raoul, Keymeulen, Bart, Mathieu, Chantal, Rottiers, Raoul, Daubresse, Jean-Claude, Rocour-Brumioul, Danielle, Pipeleers, Daniel G., Gorus, Frans K.

“…The Incidence of Type 1 Diabetes in the Age Group 0–39 Years Has Not Increased in Antwerp (Belgium) Between 1989 and 2000 Evidence for earlier disease…”
Get full text

Insulin detemir used in basal-bolus therapy in people with type 1 diabetes is associated with a lower risk of nocturnal hypoglycaemia and less weight gain over 12 months in comparison to NPH insulin by De Leeuw, I., Vague, P., Selam, J.-L., Skeie, S., Lang, H., Draeger, E., Elte, J. W. F.

“…Aim:  The aim of this study was to compare the long‐term safety and efficacy of twice‐daily insulin detemir or NPH insulin as the basal component of…”
Get full text

Relationship of body fat distribution pattern to atherogenic risk factors in NIDDM. Preliminary results by Van Gaal, L, Rillaerts, E, Creten, W, De Leeuw, I

“…Relationship of body fat distribution pattern to atherogenic risk factors in NIDDM. Preliminary results. L Van Gaal , E Rillaerts , W Creten and I De Leeuw…”
Get full text

Time Course of Oxidative Stress Status in the Postprandial and Postabsorptive States in Type 1 Diabetes Mellitus: Relationship to Glucose and Lipid Changes by Manuel-y-Keenoy, Begona, Van Campenhout, Ann, Aerts, Petra, Vertommen, Jan, Abrams, Pascale, Van Gaal, Luc F, Van Gils, Carolien, De Leeuw, Ivo H

“…Objective: The aim of this study was to compare oxidative stress status (OSS) with blood glucose and lipid changes during the fasting, postprandial and…”
Get full text